2021 Investor Alert: Amazon, Google, And Facebook Stockpile Strange Gas
This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. This is the time for investors to get in before the mainstream media.
Click HERE To See Why Big Tech Is Hoarding Gas
Helmy Eltoukhy, insider at Guardant Health
Helmy Eltoukhy Insider Alerts

Get notified the next time Helmy Eltoukhy buys or sells Guardant Health stock. Enter your email address below to get our daily insider buying and selling report.

Helmy Eltoukhy Insider Information

Helmy Eltoukhy, Ph.D. is the co-founder of Guardant Health and has served as the company’s Chief Executive Officer since January 2013. Prior to founding Guardant, Dr. Eltoukhy held various positions at Illumina, Inc., or Illumina, from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. In June 2007, he co-founded Avantome Inc. to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing and served as Chief Executive Officer until its acquisition by Illumina in August 2008. He joined the Stanford Genome Technology Center, or SGTC, as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. During his doctoral studies and at the SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several National Human Genome Research Institute grants. He received his Ph.D., M.S. and B.S. degrees in electrical engineering from Stanford University.

What is Helmy Eltoukhy's net worth?

The estimated net worth of Helmy Eltoukhy is at least $189.98 million as of April 23rd, 2021. Dr. Eltoukhy owns 1,828,514 shares of Guardant Health stock worth more than $189,982,605 as of November 30th. This net worth approximation does not reflect any other investments that Dr. Eltoukhy may own. Learn More.

What is Helmy Eltoukhy's salary?

As the CEO of Guardant Health, Inc., Dr. Eltoukhy earned a total compensation package of $113,870,986.00 in 2020. Dr. Eltoukhy earned a salary of $209,937.00, stock awards of $113,595,323.00, and other compensation of $65,726.00.

How do I contact Helmy Eltoukhy?

The corporate mailing address for Dr. Eltoukhy and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Guardant Health can also be reached via phone at (855) 698-8887 and via email at [email protected]

Has Helmy Eltoukhy been buying or selling shares of Guardant Health?

Over the course of the past ninety days, Helmy Eltoukhy has bought $10,048,620.00 in shares of Guardant Health stock. Most recently, on Tuesday, November 23rd, Helmy Eltoukhy bought 54,500 shares of Guardant Health stock. The stock was acquired at an average cost of $94.36 per share, with a total value of $5,142,620.00.

Who are Guardant Health's active insiders?

Guardant Health's insider roster includes Ian Clark (Director), Helmy Eltoukhy (CEO), Samir Kaul (Director), and Stanley Meresman (Director).

Are insiders buying or selling shares of Guardant Health?

During the last year, Guardant Health insiders bought shares 2 times. They purchased a total of 104,500 shares worth more than $10,048,620.00. During the last year, insiders at the sold shares 38 times. They sold a total of 1,440,194 shares worth more than $226,272,906.43. The most recent insider tranaction occured on November, 23rd when CEO Helmy Eltoukhy bought 54,500 shares worth more than $5,142,620.00. Insiders at Guardant Health own 5.8 % of the company.

Information on this page was last updated on 11/23/2021.

Helmy Eltoukhy Insider Trading History at Guardant Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/23/2021Buy54,500$94.36$5,142,620.00View SEC Filing Icon  
11/19/2021Buy50,000$98.12$4,906,000.00View SEC Filing Icon  
4/26/2021Sell751$160.01$120,167.511,828,514View SEC Filing Icon  
4/23/2021Sell7,388$160.12$1,182,966.561,828,514View SEC Filing Icon  
4/21/2021Sell56,358$151.76$8,552,890.081,906,556View SEC Filing Icon  
4/19/2021Sell50,932$152.97$7,791,068.042,161,187View SEC Filing Icon  
4/16/2021Sell51,123$158.34$8,094,815.822,161,187View SEC Filing Icon  
4/14/2021Sell60,982$156.54$9,546,122.282,405,525View SEC Filing Icon  
4/12/2021Sell72,861$154.59$11,263,581.992,405,525View SEC Filing Icon  
4/9/2021Sell60,996$156.86$9,567,832.562,624,751View SEC Filing Icon  
4/7/2021Sell36,843$158.61$5,843,668.232,624,751View SEC Filing Icon  
1/25/2021Sell58,811$157.26$9,248,617.862,781,007View SEC Filing Icon  
1/21/2021Sell173,206$162.01$28,061,104.063,103,275View SEC Filing Icon  
1/19/2021Sell103,717$160.12$16,607,166.043,103,275View SEC Filing Icon  
1/15/2021Sell150,000$158.39$23,758,500.003,129,518View SEC Filing Icon  
9/18/2020Sell65,422$102.09$6,678,931.982,884,952View SEC Filing Icon  
9/16/2020Sell218,509$103.92$22,707,455.283,317,456View SEC Filing Icon  
4/16/2020Sell200$70.01$14,002.003,191,084View SEC Filing Icon  
4/14/2020Sell2,701$70.06$189,232.063,191,084View SEC Filing Icon  
3/30/2020Sell178,093$69.83$12,436,234.193,472,181View SEC Filing Icon  
8/16/2019Sell253,699$100.21$25,423,176.79View SEC Filing Icon  
8/13/2019Sell426,301$99.58$42,451,053.58View SEC Filing Icon  
5/14/2019Sell78,660$72.34$5,690,264.40View SEC Filing Icon  
5/1/2019Sell131,340$65.32$8,579,128.80View SEC Filing Icon  
4/22/2019Sell90,000$65.28$5,875,200.00View SEC Filing Icon  
See Full Table

Helmy Eltoukhy Buying and Selling Activity at Guardant Health

This chart shows Helmy Eltoukhy's buying and selling at Guardant Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Guardant Health Company Overview

Guardant Health logo
Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.
Read More

Today's Range

Now: $103.90
Low: $102.80
High: $108.50

50 Day Range

MA: $110.25
Low: $92.89
High: $131.27

2 Week Range

Now: $103.90
Low: $91.19
High: $181.07


898,564 shs

Average Volume

1,101,900 shs

Market Capitalization

$10.56 billion

P/E Ratio


Dividend Yield



Biden Warns: China Could "Eat Our Lunch" When it Comes to Lithium
Pres. Biden recently warned about China's dominance when it comes to lithium demand, stating, "if we don't get moving, they're going to eat our lunch." One junior mining company in South America is looking to become a strong link in the lithium supply chain due to a monster acquisition.
Get the full scoop on this investment opportunity